Al­ly Bridge beefs up 'new gen­er­a­tion' as in­vest­ment firm pass­es 10-year mark

Al­ly Bridge Group, whose re­cent suc­cess­es in­clude CG On­col­o­gy‘s eye-pop­ping IPO, said it pro­mot­ed two peo­ple to head up its pri­vate eq­ui­ty …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA